3rd February 2017
CUE's alumni company - Owlstone Medical - raises £9.3 million financing
CUE's alumni company - Owlstone Medical - is a diagnostics company developing a breathalyzer for disease. The investment round was led by existing investors and will be used to commercially launch the company’s breath biomarker R&D services, including the opening of a new high volume clinical facility, and to fund ongoing clinical trials in lung and colon cancer screening. The funding follows the original investment of $7 million (£4.9 million) that spun Owlstone Medical out in June 2016.